Trial · NCT00989937
Oxytocin Add-on Study for Stable Anxiety Patients
NCT00989937, Not applicable, Terminated, University of California, San Diego; results first posted 2019-09-25
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Oxytocin Add-on Study for Stable Anxiety Patients. Trials, record NCT00989937. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00989937
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Oxytocin Add-on Study for Stable Anxiety Patients
- NCT number
- NCT00989937
- Status
- Terminated
- Phases
- Not applicable
- Enrollment
- 17 participants, actual
- Lead sponsor
- University of California, San Diego
- Conditions
- Anxiety Disorders
- Interventions
- Oxytocin, Placebo
- First posted
- 2009-10-06
- Last updated
- 2019-09-25
- Results first posted
- 2019-09-25
- Limitations and caveats
- The PI has left the institution and this study was terminated due to loss of funding. The data was not analyzed.
Source ClinicalTrials.gov
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Total Score on the Hamilton Anxiety Scale (HAM-A) | Performed at each visit (weekly) | |
| Secondary | Clinical Global Impression - Severity of Illness (CGI-S | Performed at each visit (weekly) | |
| Secondary | Clinical Global Impression - Global Improvement (CGI-I | Performed at each visit (weekly) | |
| Secondary | Social Phobia Inventory (SPIN) | Performed at each visit (weekly) | |
| Secondary | The State-Trait Anxiety Inventory (STAI) | Performed at each visit (weekly) | |
| Secondary | The Profile of Mood States (POMS) | Performed at each visit (weekly) | |
| Secondary | Sheehan Disability Scale (SDS) | Performed at each visit (weekly) | |
| Secondary | Arizona Sexual Experience Scale (ASEX) | Performed at each visit (weekly) | |
| Secondary | Hamilton-Depression Scale (HAM-D) | Performed at each visit (weekly) | |
| Secondary | Reading Trust in the Mind in the Eyes Test (RTET) | Visits 1, 4, 5, 8 |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 registered outcomesOutcomes12
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Total Score on the Hamilton Anxiety Scale (HAM-A) | Performed at each visit (weekly) | The PI has left the institution and this study was terminated due to loss of funding. The data was not analyzed. | ||
| SECONDARY | Clinical Global Impression - Severity of Illness (CGI-S | Performed at each visit (weekly) | The PI has left the institution and this study was terminated due to loss of funding. The data was not analyzed. | ||
| SECONDARY | Clinical Global Impression - Global Improvement (CGI-I | Performed at each visit (weekly) | The PI has left the institution and this study was terminated due to loss of funding. The data was not analyzed. | ||
| SECONDARY | Social Phobia Inventory (SPIN) | Performed at each visit (weekly) | The PI has left the institution and this study was terminated due to loss of funding. The data was not analyzed. | ||
| SECONDARY | The State-Trait Anxiety Inventory (STAI) | Performed at each visit (weekly) | The PI has left the institution and this study was terminated due to loss of funding. The data was not analyzed. | ||
| SECONDARY | The Profile of Mood States (POMS) | Performed at each visit (weekly) | The PI has left the institution and this study was terminated due to loss of funding. The data was not analyzed. | ||
| SECONDARY | Sheehan Disability Scale (SDS) | Performed at each visit (weekly) | The PI has left the institution and this study was terminated due to loss of funding. The data was not analyzed. | ||
| SECONDARY | Arizona Sexual Experience Scale (ASEX) | Performed at each visit (weekly) | The PI has left the institution and this study was terminated due to loss of funding. The data was not analyzed. | ||
| SECONDARY | Hamilton-Depression Scale (HAM-D) | Performed at each visit (weekly) | The PI has left the institution and this study was terminated due to loss of funding. The data was not analyzed. | ||
| SECONDARY | Reading Trust in the Mind in the Eyes Test (RTET) | Visits 1, 4, 5, 8 | The PI has left the institution and this study was terminated due to loss of funding. The data was not analyzed. |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 outcomesResults by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow3
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | All Participants | 0 | |
| Overall Study | COMPLETED | All Participants | 0 | |
| Overall Study | NOT COMPLETED | All Participants | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals3
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | All Participants | 0 | 0 |
| Total, other adverse events | All Participants | 0 | 0 |
| Total, serious adverse events | All Participants | 0 | 0 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00989937
GET https://conductscience.org/api/trials/v1/NCT00989937/registered